EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tandem Diabetes Care's Enterprise Value is $1,997.3 Mil.
Tandem Diabetes Care's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-212.2 Mil. Therefore, Tandem Diabetes Care's EV-to-EBIT for today is -9.41.
The historical rank and industry rank for Tandem Diabetes Care's EV-to-EBIT or its related term are showing as below:
TNDM'
s EV-to-EBIT Range Over the Past 10 Years
Min: -498.5 Med: -5.22 Max: 848.51
Current: -9.41
During the past 13 years, the highest EV-to-EBIT of Tandem Diabetes Care was 848.51. The lowest was -498.50. And the median was -5.22.
TNDM's EV-to-EBIT is ranked worse than 100% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 19.3
vs TNDM: -9.41
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tandem Diabetes Care's Enterprise Value for the quarter that ended in Dec. 2023 was $1,886.8 Mil.
Tandem Diabetes Care's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-212.2 Mil. Tandem Diabetes Care's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -11.25%.
Tandem Diabetes Care EV-to-EBIT Historical Data
The historical data trend for Tandem Diabetes Care's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Tandem Diabetes Care's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tandem Diabetes Care EV-to-EBIT Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Tandem Diabetes Care's EV-to-EBIT falls into.
Tandem Diabetes Care EV-to-EBIT Calculation
Tandem Diabetes Care's EV-to-EBIT for today is calculated as:
Tandem Diabetes Care's current Enterprise Value is $1,997.3 Mil.
Tandem Diabetes Care's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-212.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care (NAS:TNDM) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Tandem Diabetes Care's Enterprise Value for the quarter that ended in Dec. 2023 was $1,886.8 Mil.
Tandem Diabetes Care's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-212.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Tandem Diabetes Care's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Tandem Diabetes Care (Tandem Diabetes Care) Business Description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNDM has been successfully added to your 